SUPERCRITICAL IMPREGNATION OF PHARMACOACTIVE PRODUCTS IN POLYLACTIC ACID POLYMERS (PLA) SUITABLE FOR USE IN 3D PRINTING

Patent number:

PCT/ES2022/070224

No items found.

The invention comprises the production of PLA impregnated with a natural extract of Mangifera indica L. with pharmacoactive properties using supercritical technology, to manufacture with them pharmacoactive implants in biomedicine.

Countries:

Spain

Regions:

Andalusia

Centers:

UNIVERSIDAD DE CADIZ, SERVICIO ANDALUZ DE SALUD

Other entities:

Sectors:

New & Sustainable Materials

Subsectors:

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

SDG03: Good health and well-being

Applications

The implants manufactured with the product of the invention have low bioactivity values, which is attributed to the fact that the extract in the imprinted polymer is released more slowly.

Comments

P202130337

Other related patents

New & Sustainable Materials

Polymeric membranes with antiseptic capacity for food and textile applications

Countries

Spain

Energy

New & Sustainable Materials

Improved synthesis process of thin films by vapour deposition

Countries

Spain

Health

New & Sustainable Materials

ENCAPSULATED IRIDIUM(III) COMPLEXES

Countries

Spain

Get back to patents directory